Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
11K characters. Original on sec.gov · Markdown
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management
The following table sets forth certain information known to us regarding beneficial ownership of our common stock as of July 31, 2020 by:
| • | Each of the named executive officers during fiscal year 2020; |
| • | Each of our directors; |
| • | All directors and executive officers as a group; and |
| • | All person known to us beneficially own 5% or more of our outstanding common stock. |
| Name and Address of Beneficial Owner (1) | Amount and Nature of Beneficial Ownership (2) | Percent of Common Stock Outstanding (3) | |||
| Executive Officers and Directors: | |||||
| Charles Liang (4) | 7,819,865 | 14.7 | % | ||
| Kevin Bauer (5) | 69,807 | * | |||
| Don Clegg (6) | 34,954 | * | |||
| Alex Hsu (7) | 18,820 | * | |||
| George Kao (8) | 26,980 | * | |||
| David Weigand (9) | 15,109 | * | |||
| Michael S. McAndrews (10) | 27,000 | * | |||
| Hwei-Ming (Fred) Tsai (11) | 278,000 | * | |||
| Saria Tseng (12) | 21,375 | * | |||
| Sherman Tuan (13) | 40,437 | * | |||
| Sara Liu (14) | 7,819,865 | 14.7 | % | ||
| Tally Liu | — | * | |||
| Daniel Fairfax | — | * | |||
| All directors and executive officers as a group (13 persons) (15) | 8,352,347 | 15.6 | % | ||
| 5% Holders Not Listed Above: | |||||
| Oaktree Capital Management LP (16) | 3,469,505 | 6.6 | % | ||
| Empyrean Capital Overseas Master Fund, Ltd. (17) | 2,759,821 | 5.3 | % | ||
| Disciplined Growth Investors Inc. (18) | 3,821,072 | 7.3 | % | ||
| Total executives, directors & 5% or more stockholders | 34.8 | % |
- Represents beneficial ownership of less than one percent of the outstanding shares of common stock
| (1) | Except as otherwise indicated, to our knowledge the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws applicable and to the information contained in the footnotes to this table. Except as otherwise provided, the address of each stockholder listed in the table is 980 Rock Avenue, San Jose, CA 95131. |
| (2) | Under the SEC rules, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or RSUs subject to vesting. |
| (3) | Calculated on the basis of 52,436,548 shares of common stock outstanding as of July 31, 2020, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after July 31, 2020 are deemed to be outstanding for the purposes of calculating that stockholder’s percentage of beneficial ownership. |
| (4) | Includes 721,010 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. Also includes 2,668,752 shares jointly held by Mr. Liang and Sara Liu, his spouse, 389,341 shares held directly by Ms. Liu and 61,000 options exercisable within 60 days after July 31, 2020. See footnote 14. |
| (5) | Includes 61,249 shares issuable upon exercise of stock options and 938 RSUs subject to vesting, both within 60 days after July 31, 2020. |
| (6) | Includes 28,050 options exercisable and 375 RSUs subject to vesting, both within 60 days after July 31, 2020. |
| (7) | Includes 16,636 shares issuable upon the exercise of options and 237 RSUs subject to vesting, both within 60 days after July 31, 2020. |
| (8) | Includes 21,348 shares issuable upon the exercise of options and 375 RSUs subject to vesting, both within 60 days after July 31, 2020. |
| (9) | Includes 11,250 shares issuable upon the exercise of options and 625 RSUs subject to vesting within 60 days after July 31, 2020. |
| (10) | Includes 27,000 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. |
| (11) | Includes 35,000 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. |
| (12) | Includes 21,375 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. |
| (13) | Includes 35,000 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. |
| (14) | Includes 61,000 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. Also includes 2,668,752 shares jointly held by Ms. Liu and Mr. Liang, her spouse, 4,029,127 shares held by Charles Liang, and 660,010 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. See footnote 4. |
| (15) | Includes 980,468 shares issuable upon the exercise of options exercisable within 60 days after July 31, 2020. |
| (16) | The information is based solely on the Schedule 13D filed on March 19, 2020 by (i) Oaktree Value Equity Fund, L.P., a Cayman Islands exempted limited partnership (“VEF”), in its capacity as the direct owner of 2,667,482 shares of common stock; (ii) Oaktree Value Equity Fund GP, L.P., a Cayman Islands exempted limited partnership (“VEF GP”), in its capacity as the general partner of VEF; (iii) Oaktree Value Equity Fund GP Ltd., a Cayman Islands exempted company (“VEF Ltd.”), in its capacity as the general partner of VEF GP; (iv) Oaktree Capital Management, L.P., a Delaware limited partnership (“Management”), in its capacity as the sole director of VEF Ltd.; (v) Oaktree Capital Management GP, LLC, a Delaware limited liability company (“Management GP”), in its capacity as the general partner of Management; (vi) Atlas OCM Holdings, LLC, a Delaware limited liability company (“Atlas”), in its capacity as the sole managing member of Management GP; (vii) Oaktree Fund GP I, L.P., a Delaware limited partnership (“GP I”), in its capacity as sole shareholder of VEF Ltd.; (viii) Oaktree Capital I, L.P., a Delaware limited partnership (“Capital I”), in its capacity as the general partner of GP I; (ix) OCM Holdings I, LLC, a Delaware limited liability company (“Holdings I”), in its capacity as the general partner of Capital I; (x) Oaktree Holdings, LLC, a Delaware limited liability company (“Holdings”) in its capacity as the managing member of Holdings I; (xi) Oaktree Capital Group, LLC, a Delaware limited liability company (“OCG”), in its capacity as the managing member of Holdings; (xii) Oaktree Capital Group Holdings GP, LLC, a Delaware limited liability company (“OCGH”), in its capacity as the indirect owner of the class B units of each of OCG and Atlas; (xiii) Brookfield Asset Management Inc., a Canadian corporation (“BAM”), in its capacity as the indirect owner of the class A units of each of OCG and Atlas; and (xiv) Partners Limited, a Canadian corporation (“Partners”), in its capacity as the sole owner of Class B Limited Voting Shares of BAM. Except as set forth in Schedule A to the Scheudle 13D, the address of the business office of each of the reporting persons and covered persons is c/o Oaktree Capital Management, L.P., 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071. |
| (17) | The information is based solely on the Schedule 13G filed on January 3, 2020 by (i) Empyrean Capital Overseas Master Fund, Ltd. ("ECOMF"), a Cayman Islands exempted company, with respect to the common stock directly held by it, and has shared voting and dispositive power over 2,679,893 shares of common stock; (ii) P EMP Ltd. ("P EMP" and collectively with ECOMF, the "Empyrean Clients"), a British Virgin Islands business company, with respect to the common stock directly held by it, and has shared voting and dispositive power over 79,928 shares of common stock; (iii) Empyrean Capital Partners, LP ("ECP"), a Delaware limited partnership, which serves as investment manager to the Empyrean Clients with respect to the common stock directly held by the Empyrean Clients, and has shared voting and dispositive power over 2,759,821 shares of common stock; and (iv) Mr. Amos Meron, who serves as the managing member of Empyrean Capital, LLC, the general partner of ECP, with respect to the common stock directly held by the Empyrean Clients, and has shared voting and dispositive power over 2,759,821 shares of common stock. The address of the business office of each of the reporting persons is c/o Empyrean Capital Partners, LP, 10250 Constellation Boulevard, Suite 2950, Los Angeles, CA 90067. |
| (18) | The information is based solely on the Schedule 13-F filed on August 14, 2020. The address for the reporting person is 150 S. Fifth St. Suite 2550, Minneapolis, MN 55402. |
Equity Compensation Plan Information
We currently maintain three compensation plans that provide for the issuance of our Common Stock to officers and other employees, directors and consultants. These consist of the 2006 Equity Incentive Plan, the 2016 Equity Incentive Plan and the 2020 Plan. All three of these plans have been approved by our stockholders. We no longer grant any equity-based awards under the 2006 Equity Incentive Plan or the 2016 Equity Incentive Plan. The following table sets forth information regarding
outstanding options, RSUs, and PRSUs and shares reserved and remaining available for future issuance under the foregoing plans as of June 30, 2020:
| Plan Category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)(1) | Weighted-average exercise price of outstanding options, warrants and rights (b)(2)(3) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)(c) | ||||||
| Equity compensation plans approved by security holders | 7,189,795 | $ | 19.38 | 5,249,198 | |||||
| Equity compensation plans not approved by security holders | — | — | — | ||||||
| Total | 7,189,795 | 5,249,198 |
| (1) | This number includes 5,379,768 shares subject to outstanding options, 1,768,027 shares subject to outstanding RSU awards, and 42,000 shares subject to outstanding PRSU awards. |
| (2) | The weighted average exercise price is calculated based solely on the exercise prices of the outstanding options and does not reflect the shares that will be issued upon the vesting of outstanding awards of RSUs and PRSUs, which have no exercise price. |
| (3) | The weighted-average remaining contractual term of our outstanding options as of June 30, 2020 was 4.07 years. |
Previous: Item 11. Executive Compensation · Next: Item 13. Certain Relationships and Related Transactions and Director Independence